510(k) Report

510(k) · Cleared

Recalled · Class II · 2013

Hemocue Hemoglobin 201 + System Article 121704

K032203510(k) SpecialCleared Aug 25, 200338-day reviewClass II21 CFR 864.5620Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hemocue, Inc. · GKR System, Hemoglobin, Automated

Cleared on Aug 25, 2003 after a 38-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 7 later devices descend from it. It has been recalled once.

Decided
Aug 25, 2003
Review
38 days
Class
Class II
Product code
GKR
Recalls
1
Predicates
0

7 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2023: 1 descendant cleared2017: 2 descendants cleared2006: 1 descendant cleared2019: 1 descendant cleared2018: 1 descendant cleared2020: 1 descendant cleared200020052010201520202025
  1. This deviceK032203 Hemocue Hemoglobin 201 + System Article 121704Hemocue, Inc. · 2003
  2. Descendant · cites it directly · 4 of its ownK061047 Hemocue HB 301 Analyzer, Model 121804 and Microcuvettes, Model 111801Hemocue AB · 2006
  3. Descendant · 2 generations on · 1 of its ownK181751 HemoCue Hb 801 SystemHemocue AB · 2019
  4. Descendant · cites it directly · 0 of its ownK221508 AnemoCheck HomeSanguina, Inc. · 2023
  5. Descendant · 3 generations on · 0 of its ownK201217 HemoCue Hb 301 SystemHemocue AB · 2020
  6. Descendant · 2 generations on · 0 of its ownK182298 hemochroma PLUS SystemImmunostics Inc., · 2018

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2006: 12017: 22018: 12019: 12020: 12023: 1
2006high 2 (2017) · low 0 (2007)2026

Most influential descendants

Showing 5 of 7 · See all
  • K061047Hemocue HB 301 Analyzer, Model 121804 and Microcuvettes, Model 111801Hemocue AB · 2006 · cites it directly4descendants
  • K181751HemoCue Hb 801 SystemHemocue AB · 2019 · 2 generations on1descendant
  • K221508AnemoCheck HomeSanguina, Inc. · 2023 · cites it directly0descendants
  • K201217HemoCue Hb 301 SystemHemocue AB · 2020 · 3 generations on0descendants
  • K182298hemochroma PLUS SystemImmunostics Inc., · 2018 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K032203Hemocue Hemoglobin 201 + System Article 121704Hemocue, Inc.2003—
+1K061047Hemocue HB 301 Analyzer, Model 121804 and Microcuvettes, Model 111801Hemocue AB2006—
+2K181751HemoCue Hb 801 SystemHemocue AB2019—
+1K221508AnemoCheck HomeSanguina, Inc.2023—
+3K201217HemoCue Hb 301 SystemHemocue AB2020—
+2K182298hemochroma PLUS SystemImmunostics Inc.,2018—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
201720
201810
201910
202010
202310
FIG. 1 — Lineage of K032203, 2003–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GKR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GKR device

  1. #1 K201217 HemoCue Hb 301 Systemscore 0.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (7)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K061047Hemocue HB 301 Analyzer, Model 121804 and Microcuvettes, Model 111801Hemocue AB20064
K221508AnemoCheck HomeSanguina, Inc.20230
K163215AnemoCheckSanguina, LLC20170

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 25, 2013Class IIZ-0101-2014PackagingHemoCue AB has become aware of a production related problem involving punctured HemoCue Hb 201 Microcuvettes single pack pouches.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K061047 (Hemocue AB, 2006) has gone furthest, with 4 descendants of its own.

How does its category compare?

All GKR devices

GKR System, Hemoglobin, Automated: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GKR

2in 2020

2008: 12009: 12011: 12013: 22017: 12018: 22019: 12020: 2
2007high 2 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GKR

Too few GKR 510(k)s in any year since 2007 to give a median.

Recalls per year · GKR

1in 2013

2010: 12011: 12013: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GKR

1in 2024

2008: 22009: 162010: 92011: 122012: 252013: 432014: 312015: 192016: 92019: 92020: 12021: 12022: 12024: 1
2007high 43 (2013) · low 0 (2007)2025

MAUDE reports naming product code GKR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—02
20091—016
20100—19
20111—112
20120—025
20132—143
20140—031
20150—019
20160—09
20171—00
20182—00
20191—09
20202—01
20210—01
20220—01
20230—00
20240—01
20250—00
20260—0—

What is it indicated for?

Quantitative determination of hemoglobin in capillary, venous and arterial whole blood. The HemoCueB Hb 201 Microcuvettes are intended for use in the HemoCueB Hb 20 1' analyzer. The HemoCue 20 1 system is used for the quantitative determination of hemoglobin in blood using a specially designed analyzer, the HemoCue Hb 20 1' analyzer, and specially designed microcuvettes the HemoCue Hb 201 Microcuvettes. The HemoCue Hb 201' analyzer is only to be used…

Read the full statement (150 words)

Quantitative determination of hemoglobin in capillary, venous and arterial whole blood.

The HemoCueB Hb 201 Microcuvettes are intended for use in the HemoCueB Hb 20 1' analyzer. The HemoCue 20 1 system is used for the quantitative determination of hemoglobin in blood using a specially designed analyzer, the HemoCue Hb 20 1' analyzer, and specially designed microcuvettes the HemoCue Hb 201 Microcuvettes. The HemoCue Hb 201' analyzer is only to be used with HemoCue Hb 201 Microcuvettes.

The reagents/microcuvettes and the analyzer form an analytical system. The HemoCue Hb 20 1' analyzer is only to be used together with HemoCue Hb 20 1 microcuvettes. The use of any other device in the HemoCue Hb 201' analyzer except the HemoCue Hb 201 microcuvettes is neither supported nor recommended by HemoCue, and could give erroneous results with serious clinical consequences.

The HemoCue Hb 201 microcuvettes are for in vitro diagnostic use only.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K032203: Hemocue Hemoglobin 201 + System Article 121704.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K032203

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026